Genetic Mechanisms of Pituitary Hormone Deficiencies

The pituitary gland orchestrates growth, metabolism and reproduction through distinct hormone axes. Genetic defects perturbing its embryonic development or hormone biosynthesis give rise to congenital hypopituitarism, a condition marked by one or more hormone deficiencies from birth. Key mechanisms include loss-of-function variants in transcription factors responsible for pituitary cell specification (for example PROP1, POU1F1, HESX1, LHX3 and LHX4), mutations affecting hormone-specific genes (such as GH1 and GHRHR) and disruptions in major developmental signalling pathways (including SHH, WNT and NOTCH). Both monogenic and oligogenic inheritance patterns have been described, with compound heterozygous or synergistic variants increasingly recognised. Model organisms, particularly gene-knockout mice, have been instrumental in validating candidate genes and uncovering novel molecular networks governing pituitary organogenesis. Despite advances in next-generation sequencing, a substantial proportion of patients remain without a definitive molecular diagnosis. Elucidation of these genetic mechanisms underpins early screening, personalised genetic counselling and optimisation of hormone replacement therapies, with significant implications for long-term growth and metabolic health.

Research from Nature Portfolio

No recent Nature Portfolio content available.

Genetic Mechanisms of Pituitary Hormone Deficiencies publication trend

The graph below shows the total number of articles in genetic mechanisms of pituitary hormone deficiencies across all publications each year (not limited to Nature Index journals).

Technical terms

Congenital hypopituitarism: A birth-onset condition characterised by partial or complete deficiency of one or more pituitary hormones due to genetic or developmental anomalies.

Pituitary stalk interruption syndrome: A developmental disorder marked by absence, thinning or discontinuity of the pituitary stalk, leading to varying degrees of anterior pituitary hormone deficiency.

Whole exome sequencing: A genomic technique that sequences all protein-coding regions of the genome to detect sequence variants associated with disease.

Knockout mouse model: A laboratory mouse in which a specific gene has been inactivated to study the gene’s role in physiology and disease.

Transcription factor: A protein that binds to specific DNA sequences and regulates the transcription of target genes, crucial for cell differentiation and organ development.

References

1. Knockout mice with pituitary malformations help identify human cases of hypopituitarism. Genome Medicine (2024).
2. Identification of genetic variants and phenotypic characterization of a large cohort of patients with congenital hypopituitarism and related disorders. Genetics in Medicine (2023).
3. Re-analysis of gene mutations found in pituitary stalk interruption syndrome and a new hypothesis on the etiology. Frontiers in Endocrinology (2024).